This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
(Updates from 10:45 a.m. ET with closing information.)
NEW YORK (
TheStreet) -- Here's what Jim Cramer had to say on
CNBC's "Squawk On The Street" Thursday:
Cramer noted how strong
Biogen Idec(BIIB - Get Report) stock is even though the company's ALS drug failed. "I think this is a great company," Cramer said. BIIB shares closed down 1.4% Thursday.
Surprised at Stifel Nicolaus upgrading both
DR Horton(DHI - Get Report) and
Toll Brothers(TOL - Get Report), Cramer said, "It's a bit late," then added, "This is the impetus behind the group going up." DHI and TOL both closed flat.
Cramer thinks the
Cisco(CSCO - Get Report) upgrade to outperform by RBC is important. "Cisco is doing better than people think," he said. CSCO closed up 1%.
Following another upgrade on
Priceline.com(PCLN - Get Report), Cramer called it "the last darling standing." PCLN was up 1.6%.
Huntsman(HUN - Get Report), Cramer said its new CEO could stabilize and take the stock to $20 a share. HUN ended the day up 3.3%.
By contrast, calling it the disaster du jour, Cramer pointed to the stock falloff at
Mellanox Technologies(MLNX - Get Report) after the CFO left. "Ask Herb Greenberg," he said of his
CNBC colleague. "That's all you need to know." MLNX plummeted 17% Thursday.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.-- Written by Anthony Buccino in New York.